Back to top
more

Anthem, Inc. (ANTM)

(Delayed Data from NYSE)

$261.70 USD

261.70
1,184,666

+0.11 (0.04%)

Updated May 3, 2019 04:00 PM ET

After-Market: $261.69 (%) 5:22 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

NA

Industry: NA

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Based in Indianapolis, IN, and formed through the merger of Anthem Inc. and WellPoint Health Networks Inc. in Nov 2004, Anthem Inc. is one of the largest publicly traded managed care organizations in terms of membership. The company was previously named WellPoint Inc. (WLP). The company is also an independent licensee of the Blue Cross Blue Shield Association (BCBSA). Anthem is the largest BCBS plan provider in the United States. As of Mar 31, 2020, it catered to 42.1 million medical members through its affiliated health plans.

Why Retaining Cigna (CI) Stock for Now is a Prudent Move?

by Zacks Equity Research

Cigna (CI) expects growth of at least 350,000 customers in 2021 to ramp up total medical clients.

Centene (CNC) Up 4.8% on Upbeat '22 Guidance: Key Details

by Zacks Equity Research

Centene (CNC) expects bottom-line growth to be supported by lower expenses and gross margin improvement.

UnitedHealth's (UNH) Arms Receive Rating Actions From AM Best

by Zacks Equity Research

UnitedHealth's (UNH) subsidiaries get rating upgrades from AM Best. Moreover, outlook of the ratings is revised to stable.

Mark Vickery headshot

Top Stock Reports for Microsoft, NVIDIA & Medtronic

by Mark Vickery

Today's Research Daily features new research reports on 16 major stocks, including Microsoft Corporation (MSFT), NVIDIA Corporation (NVDA), and Medtronic plc (MDT).

UnitedHealth (UNH) Ups Guidance: Here's What You Should Know

by Zacks Equity Research

UnitedHealth's (UNH) 2022 bottom line estimates are below the Zacks Consensus Estimate, may be due to an uptick in insurance claims triggered by the coronavirus pandemic.

Anthem (ANTM) Down 1.1% Since Last Earnings Report: Can It Rebound?

by Zacks Equity Research

Anthem (ANTM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Anthem (ANTM) to Acquire Integra to Enhance Medicaid Business

by Zacks Equity Research

Anthem (ANTM) to buy Integra Managed Care from a wholly-owned indirect unit of Personal Touch Holding Corporation to bolster its Medicaid Business profile.

Cigna (CI) to Post Earnings in Q3: What's in the Offing?

by Zacks Equity Research

Cigna's (CI) Q3 results are likely to reflect growth in earnings and revenues.

Acadia Healthcare (ACHC) Q3 Earnings Meet Estimates, Rise Y/Y

by Zacks Equity Research

Acadia Healthcare's (ACHC) Q3 results reflect higher revenues, driven by solid demand for its behavioral health services and higher admissions.

Should You Invest in the iShares U.S. Healthcare Providers ETF (IHF)?

by Zacks Equity Research

Sector ETF report for IHF

Encompass Health (EHC) Misses on Q3 Earnings, Cuts '21 EPS View

by Zacks Equity Research

Encompass Health's (EHC) third-quarter earnings miss estimates but improve year over year on the back of top-line growth resulting from a sound Inpatient Rehabilitation segment.

Universal Health (UHS) Q3 Earnings Miss Mark, Decline Y/Y

by Zacks Equity Research

Universal Health's (UHS) third-quarter results reflect high expenses, partly offset by better revenues.

Centene's (CNC) Q3 Earnings Miss Estimates, Revenues Up Y/Y

by Zacks Equity Research

Centene's (CNC) third-quarter results reflect improved revenues, better Medicare and Medicaid membership growth, partly offset by higher SG&A costs.

Breast Health Sales to Drive Hologic's (HOLX) Q4 Earnings

by Zacks Equity Research

The acquisition of Biotheranostics and the launch of new software are expected to have contributed to Hologic's (HOLX) Breast Health arm performance in the fourth quarter.

Srijita Guha headshot

4 Healthcare Stocks to Top Q3 Estimates Amid Coronavirus Woes

by Srijita Guha

Factors like an aging populace and demand for products and services are likely to reflect on the Q3 results of ACAD, MD, ACHC and VRTX.

Hologic (HOLX) to Report Q4 Earnings: What's in the Cards?

by Zacks Equity Research

Hologic's (HOLX) recent acquisitions and product launches are expected to contribute significantly to its fourth-quarter performance.

HCA Healthcare (HCA) Q3 Earnings Beat Estimates, Surge Y/Y

by Zacks Equity Research

HCA Healthcare's (HCA) Q3 earnings results reflect gains from patient volumes and better revenues.

Tenet Healthcare (THC) Q3 Earnings Beat Mark, Increase Y/Y

by Zacks Equity Research

Tenet Healthcare's (THC) third-quarter earnings results reflect better revenues and higher patient volumes.

Stock Market News for Oct 21, 2021

by Zacks Equity Research

The Dow and the S&P 500 ended near an all-time high on Wednesday, lifted by the Federal Reserve's latest Beige Book report that points to a modest growth pace of the US economy, and upbeat third-quarter earnings report.

Anthem's (ANTM) Q3 Earnings Beat Estimates, Increase Y/Y

by Zacks Equity Research

Anthem's (ANTM) third-quarter results reflect higher revenues and solid contribution from its segments.

Anthem (ANTM) Q3 Earnings and Revenues Surpass Estimates

by Zacks Equity Research

Anthem (ANTM) delivered earnings and revenue surprises of 6.93% and 0.60%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

Is a Surprise Coming for Anthem (ANTM) This Earnings Season?

by Zacks Equity Research

Anthem (ANTM) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Hologic (HOLX) to Expand Surgical Portfolio With Bolder Buyout

by Zacks Equity Research

Hologic's (HOLX) recent acquisition will accelerate its growth and enhance patient outcomes by leveraging significant commercial resources and strong relationships with OB/GYN specialists.

Why Anthem (ANTM) Could Beat Earnings Estimates Again

by Zacks Equity Research

Anthem (ANTM) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

by Zacks Equity Research

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.